- 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests | BBC News BBC News —
- Much-hyped Alzheimer’s drugs do not help patients, review finds The Straits Times —
- Alzheimer’s drugs ‘make no meaningful difference to patients,’ major review suggests The Independent —
- Dementia drugs hailed as 'beginning of the end' for Alzheimer's do not work, major report finds Daily Mail —
- Alzheimer’s drugs targeting amyloid don’t help, review finds The Japan Times —
- Effect of ‘gamechanger’ Alzheimer’s drugs ‘trivial’, review concludes The Guardian —
- Analysis of Alzheimer’s Drugs Stirs Debate About Their Effectiveness The New York Times —
- Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers Belfast Telegraph —
- New Alzheimer’s drugs make ‘no meaningful difference’ to patients The Times —
- Alzheimer’s bombshell as top scientists conclude - ‘the drugs don’t work’ Mirror —
- Alzheimer's drugs make 'no meaningful difference' RTE —
- The surprising value of boring chats, ‘super El Niño’ and Alzheimer’s evidence reviewed – podcast The Guardian —
- Alzheimer’s drugs ‘make no meaningful difference to patients’, say researchers The Standard —
- 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests BBC News —
- Alzheimer's 'wonder drugs' do not work, major study finds despite hopes of end to disease LBC —
- What’s the deal with Alzheimer’s disease and amyloid? Ars Technica —
Alzheimer's disease
Progressive, neurodegenerative disease characterized by memory loss
Alzheimer's disease (AD) is a neurodegenerative disease and is the most common form of dementia, accounting for around 60–70% of cases. The most common early symptom is difficulty in remembering recent events. As the disease advances, symptoms can include problems with language, disorientation, mood swings, loss of motivation, self-neglect, and behavioral issues. As a person's condition declines, they often withdraw from family and society. Gradually, bodily functions are lost, ultimately leading to death. Although the speed of progression can vary, the average life expectancy following diagnosis is three to twelve years.
Also known as...
Alzheimer, Alzheimers, AD, Alzheimer disease, Alzheimer's dementia, Alzheimers dementia, Alzheimer disease, familial, Alzheimer dementia, Alzheimers disease, and Alzheimer’s Disease
Alzheimer's Breakthrough Drugs Questioned